| Drug Name |
Micafungin |
| Drug ID |
BADD_D01455 |
| Description |
Micafungin is an antifungal drug. It belongs to the antifungal class of compounds known as echinocandins and exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall. |
| Indications and Usage |
Indicated for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, as well as esophageal candidiasis, and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. Micafungin is also used as an alternative for the treatment of oropharyngeal candidiases and has been used with some success as primary or salvage therapy, alone or in combination with other antifungals, for the treatment of invasive aspergillosis.
Indicated for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. |
| Marketing Status |
approved; investigational |
| ATC Code |
J02AX05 |
| DrugBank ID |
DB01141
|
| KEGG ID |
D08218
|
| MeSH ID |
D000077551
|
| PubChem ID |
477468
|
| TTD Drug ID |
D06TOE
|
| NDC Product Code |
16714-301; 70710-1725; 60505-6120; 70771-1683; 60505-6119; 70771-1684; 42023-229; 16714-164; 70710-1724; 42023-230 |
| UNII |
R10H71BSWG
|
| Synonyms |
Micafungin | FK 463 | FK463 | FK-463 | Micafungin Sodium | Mycamine |
